Banking and Finance Government Departments Closing in 0 days TDR #15909515

Drugs and Pharmaceutical, Drugs and Medicine, Medicine

Issued by Government Departments · New Delhi, Delhi
Tender Value
Ref. Documents
Estimated cost
Bid Submission
22 May 2018
0 days left
EMD
Ref. Documents
Bank guarantee accepted
Document Fee
Ref. Documents
Non-refundable
Tender Type
Online

Tender Overview

Competition Type
NCB
Bidding Type
Tender
Location / State
New Delhi → Delhi
EMD Exemption
Not Available
Quantity
Not Available

Project Description

supply of Rate Contract for Testing Of Drugs- INJECTION- DEXTROSE 5% INJ (IV FLUIDS) - Each to contain: Dextrose 5% Self Collapsible I.V. Fluid PVC Bag having separate administration port with recessed membrane with plastic sterility barrier & self sealing Inj. Port with silicone septum, no air vent required, INJECTION - DEXTROSE 10% INJ (IV FLUIDS) - Each to contain: Dextrose 10% Self Collapsible I.V. Fluid PVC Bag having separate administration port with recessed membrane with plastic sterility b- NORMAL SALINE INJ(IV FLUIDS) - Each to contain: Normal Saline Self Collapsible IV Fluid PVC Bag having separate administration port with recessed membrane with plastic sterility barrier & self sealing Inj port with silicone septum, no air vent required.INJECTION BORTEZOMIB 1MG INJ - Each vial to contain: Bortezomib 1 mg INJECTION Inj. Bortezomib 3.5 mg INJECTION CABAZITAXEL INJ - Each 1.5ml contains: Cabazitaxel 60mg Diluent 5.7ml of 13% w/w Ethanol in water for injection INJECTION CETUXIMAB 100MG INJ - Each ml to contain: Cetuximab 5mg INJECTION CETUXIMAB 500MG INJ - Each ml to contain: Cetuximab 5mg INJECTION IMMUNOGLOBULIN - Each to contain: Rho (D) Immune Globulin (Human) 300 mcg.(1500 IU). INJECTION FACTOR EIGHT BYPASSING ACTIVITY - Containing : Factor Eight Bypassing activity, Anti-Inhibitor- Coagulant Complex. 500 IU. INJECTION RECOMBINANT ANTI HEMOPHILLIC FACTOR-VIII - Containing : Recombinant Anti Hemophillic Factor-VIII 250 IU INJECTION RECOMBINANT ANTI HEMOPHILLIC FACTOR-VIII - Containing : Recombinant Anti Hemophillic Factor-VIII 500 IU INJECTION RECOMBINANT ANTI HEMOPHILLIC FACTOR-VIII - Containing : Recombinant Anti Hemophillic Factor-VIII 1000 IU, INJECTION IMMUNOGLOBULIN - Each 1 ml solution contain : Active substance(s) Human plasma proteins 50 mg, IgM 6 mg (12%) , IgA 6 mg (12%) IgG 38 mg (76%), INJECTION VERAPAMIL INJ - Each ml to contain: Verapamil 2.5mg.

AI Tender Summary

OUR REF NO 15909515
AUTHORITY Government Departments
TENDER VALUE Ref. Documents
LAST DATE 22-05-2018
Authority
Authority Name Employees State Insurance Corporation
Work Description supply of Rate Contract for Testing Of Drugs- INJECTION- DEXTROSE 5% INJ (IV FLUIDS) - Each to contain: Dextrose 5% Self Collapsible I.V. Fluid PVC Bag having separate administration port with recessed membrane with plastic sterility barrier & self sealing Inj. Port with silicone septum, no air vent required, INJECTION - DEXTROSE 10% INJ (IV FLUIDS) - Each to contain: Dextrose 10% Self Collapsible I.V. Fluid PVC Bag having separate administration port with recessed membrane with plastic sterility b- NORMAL SALINE INJ(IV FLUIDS) - Each to contain: Normal Saline Self Collapsible IV Fluid PVC Bag having separate administration port with recessed membrane with plastic sterility barrier & self sealing Inj port with silicone septum, no air vent required.INJECTION BORTEZOMIB 1MG INJ - Each vial to contain: Bortezomib 1 mg INJECTION Inj. Bortezomib 3.5 mg INJECTION CABAZITAXEL INJ - Each 1.5ml contains: Cabazitaxel 60mg Diluent 5.7ml of 13% w/w Ethanol in water for injection INJECTION CETUXIMAB 100MG INJ - Each ml to contain: Cetuximab 5mg INJECTION CETUXIMAB 500MG INJ - Each ml to contain: Cetuximab 5mg INJECTION IMMUNOGLOBULIN - Each to contain: Rho (D) Immune Globulin (Human) 300 mcg.(1500 IU). INJECTION FACTOR EIGHT BYPASSING ACTIVITY - Containing : Factor Eight Bypassing activity, Anti-Inhibitor- Coagulant Complex. 500 IU. INJECTION RECOMBINANT ANTI HEMOPHILLIC FACTOR-VIII - Containing : Recombinant Anti Hemophillic Factor-VIII 250 IU INJECTION RECOMBINANT ANTI HEMOPHILLIC FACTOR-VIII - Containing : Recombinant Anti Hemophillic Factor-VIII 500 IU INJECTION RECOMBINANT ANTI HEMOPHILLIC FACTOR-VIII - Containing : Recombinant Anti Hemophillic Factor-VIII 1000 IU, INJECTION IMMUNOGLOBULIN - Each 1 ml solution contain : Active substance(s) Human plasma proteins 50 mg, IgM 6 mg (12%) , IgA 6 mg (12%) IgG 38 mg (76%), INJECTION VERAPAMIL INJ - Each ml to contain: Verapamil 2.5mg.
Basic Detail
Tender No
Bidding Type Tender
Location
City New Delhi
State Delhi
Key Dates
Publish Date 26 Apr 2018
Submission Date 22 May 2018
Open Date 01 Jan 0001
Finance
Tender Value Ref. Documents
Tender Fee Ref. Documents
EMD Ref. Documents
Exemption Not Available
Document List
bbcb9408-333a-4d1d-8b53-700711c34700.rar

Unlock Full AI Tender Summary

Get instant access to the complete AI-generated analysis — scope, eligibility, timeline & more.

Instant Access Secure Free
Your details are secure and used only for document delivery.

Tender Timeline

Jan 01, 1900
11:30 IST

Tender Published

Tender notice published.

Completed
May 22, 2018
17:00 IST

Bid Submission Deadline

Online submission via eProcurement portal.

Completed

Tender Documents

Download All (ZIP) ↓
rar

bbcb9408-333a-4d1d-8b53-700711c34700.rar

Disclaimer

We takes all possible care for accurate & authentic tender information. However users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender

TenderDetail
Loading tenders